Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Ascendis Pharma A (ASND) over the last 14 years, with Q3 2025 value amounting to $3764.4.

  • Ascendis Pharma A's Shares Outstanding (Diluted Average) fell 4219.75% to $3764.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $3764.4, marking a year-over-year decrease of 4219.75%. This contributed to the annual value of $7.0 million for FY2023, which is 23.15% up from last year.
  • As of Q3 2025, Ascendis Pharma A's Shares Outstanding (Diluted Average) stood at $3764.4, which was down 4219.75% from $2513.0 recorded in Q2 2025.
  • Ascendis Pharma A's 5-year Shares Outstanding (Diluted Average) high stood at $8.1 million for Q4 2021, and its period low was $1662.0 during Q1 2025.
  • Over the past 5 years, Ascendis Pharma A's median Shares Outstanding (Diluted Average) value was $4520.9 (recorded in 2023), while the average stood at $1.6 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first soared by 1757.07% in 2024, then tumbled by 4457.17% in 2025.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Shares Outstanding (Diluted Average) stood at $8.1 million in 2021, then decreased by 13.6% to $7.0 million in 2022, then rose by 0.23% to $7.0 million in 2023, then tumbled by 99.91% to $6512.4 in 2024, then plummeted by 42.2% to $3764.4 in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $3764.4 for Q3 2025, versus $2513.0 for Q2 2025 and $1662.0 for Q1 2025.